Health service utilisation and costs of treatment with either exenatide twice daily or basal insulin for patients with type 2 diabetes: a retrospective UK study

Morgan C L, Jenkins-Jones S, Currie C J, Berni E R, Holden S E, Qiao Q. 09 Feb 2016

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services